| Drug Name | Tysabri (NATALIZUMAB) |
|---|---|
| Drug Class |
Immunosuppressant
|
| Risk minimization type |
Patient Card
Direct Healthcare Professional Communication DHPC
Healthcare provider guide
patient guide
|
| Specialty (Theraputic area) |
Neurology
|
| Risk |
Risk of progressive multifocal leukoencephalopathy PML |
| Patient card |
|
| patient guide |
|
| Health care provider guide |
|
| Dear Healthcare provider letter DHPC |
|
| other |
|